Cargando…
The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade
AIMS: ST-elevation myocardial infarction is associated with high levels of cardiac sympathetic drive and release of the co-transmitter neuropeptide Y (NPY). We hypothesized that despite beta-blockade, NPY promotes arrhythmogenesis via ventricular myocyte receptors. METHODS AND RESULTS: In 78 patient...
Autores principales: | Kalla, Manish, Hao, Guoliang, Tapoulal, Nidi, Tomek, Jakub, Liu, Kun, Woodward, Lavinia, Dall’Armellina, Erica, Banning, Adrian P, Choudhury, Robin P, Neubauer, Stefan, Kharbanda, Rajesh K, Channon, Keith M, Ajijola, Olujimi A, Shivkumar, Kalyanam, Paterson, David J, Herring, Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299634/ https://www.ncbi.nlm.nih.gov/pubmed/31834357 http://dx.doi.org/10.1093/eurheartj/ehz852 |
Ejemplares similares
-
Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction
por: Herring, Neil, et al.
Publicado: (2019) -
Neuropeptide‐Y Levels in ST‐Segment–Elevation Myocardial Infarction: Relationship With Coronary Microvascular Function, Heart Failure, and Mortality
por: Gibbs, Thomas, et al.
Publicado: (2022) -
RNA Sequencing Reveals Novel Transcripts from Sympathetic Stellate Ganglia During Cardiac Sympathetic Hyperactivity
por: Bardsley, Emma N., et al.
Publicado: (2018) -
Coronary Sinus Neuropeptide Y Levels and Adverse Outcomes in Patients With Stable Chronic Heart Failure
por: Ajijola, Olujimi A., et al.
Publicado: (2020) -
The Role of Neuropeptide Y in Cardiovascular Health and Disease
por: Tan, Cheryl M. J., et al.
Publicado: (2018)